PRTN3 and rheumatoid arthritis: We identified 55 and 38 enriched biological processes from the targets of the aforementioned autoantibodies higher in ACPA+ RA and ACPA− RA, respectively (P < 0.05, Fig. 4A and Supplementary Table 8).